Revenue
$5.13B
Fiscal year ended 2026-03-31Operating income
$515.00M
Fiscal year ended 2026-03-31Free cash flow
Unavailable
Fiscal year ended 2026-03-31GE HealthCare Technologies Inc. (GEHC) reported revenue of $5.13B and net income of $389.00M for the fiscal year ended 2026-03-31. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from GE HealthCare Technologies Inc.’s SEC filings, each linked to the filing it came from.
Income
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5.13B | $5.70B | $5.14B | $5.01B | $4.78B | $5.32B | $4.86B | $4.84B | $4.65B | $5.21B |
| Cost of revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross profit | $1.98B | $2.26B | $1.99B | $1.98B | $2.01B | $2.28B | $2.03B | $2.00B | $1.90B | $2.16B |
| Operating income | $515.00M | $827.00M | $653.00M | $654.00M | $629.00M | $801.00M | $676.00M | $608.00M | $540.00M | $689.00M |
| Net income | $389.00M | $589.00M | $446.00M | $486.00M | $564.00M | $721.00M | $470.00M | $428.00M | $374.00M | $403.00M |
| Research & development | $345.00M | $323.00M | $292.00M | $302.00M | $344.00M | $344.00M | $316.00M | $327.00M | $324.00M | $315.00M |
| Weighted-average diluted shares | shares 457.00M | Unavailable | shares 457.00M | shares 458.00M | shares 459.00M | Unavailable | shares 459.00M | shares 459.00M | shares 459.00M | Unavailable |
| Pretax income | $505.00M | $821.00M | $643.00M | $613.00M | $692.00M | $834.00M | $658.00M | $578.00M | $512.00M | $609.00M |
| Income tax expense | $94.00M | $219.00M | $179.00M | $113.00M | $104.00M | $96.00M | $168.00M | $143.00M | $124.00M | $193.00M |
| Diluted EPS | $0.85 | Unavailable | $0.98 | $1.06 | $1.23 | Unavailable | $1.02 | $0.93 | $0.81 | Unavailable |
| Selling, general & administrative | $1.12B | $1.11B | $1.04B | $1.03B | $1.04B | $1.13B | $1.03B | $1.07B | $1.04B | $1.15B |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2.26B | $4.49B | $4.00B | $3.74B | $2.45B | $2.87B | $3.55B | $2.00B | $2.55B | $2.49B |
| Total assets | $37.12B | $36.91B | $36.13B | $35.50B | $33.59B | $33.09B | $33.86B | $31.85B | $32.21B | $32.45B |
| Current assets | $10.43B | $12.50B | $11.89B | $11.31B | $9.74B | $9.90B | $10.64B | $8.81B | $9.37B | $9.41B |
| Total liabilities | $26.23B | $26.31B | $25.91B | $25.55B | $24.17B | $24.44B | $25.34B | $23.86B | $24.61B | $25.14B |
| Current liabilities | $8.53B | $9.10B | $10.07B | $9.75B | $9.97B | $9.55B | $8.67B | $8.32B | $8.86B | $8.98B |
| Total equity incl. NCI | $10.68B | $10.39B | $10.02B | $9.73B | $9.21B | $8.46B | $8.34B | $7.82B | $7.42B | $7.14B |
| Temporary (mezzanine) equity | $218.00M | $209.00M | $204.00M | $220.00M | $211.00M | $188.00M | $177.00M | $177.00M | $177.00M | $165.00M |
| Inventory | $2.35B | $2.23B | $2.30B | $2.28B | $2.16B | $1.94B | $2.12B | $2.02B | $1.99B | $1.96B |
| Accounts receivable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Goodwill | $15.06B | $13.49B | $13.44B | $13.42B | $13.37B | $13.14B | $13.14B | $13.12B | $12.93B | $12.94B |
| Long-term debt | $10.13B | $9.50B | $8.28B | $8.27B | $6.76B | $7.45B | $9.31B | $8.23B | $8.25B | $8.44B |
| Accounts payable | $3.41B | $3.25B | $2.99B | $2.98B | $3.15B | $3.04B | $2.91B | $2.82B | $2.93B | $2.95B |
Cash flow
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $290.00M | Unavailable | Unavailable | $94.00M | $250.00M | Unavailable | Unavailable | -$119.00M | $419.00M | Unavailable |
| Capital expenditures | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Investing cash flow | -$2.50B | -$269.00M | -$148.00M | -$223.00M | -$407.00M | -$240.00M | -$137.00M | -$349.00M | -$188.00M | -$88.00M |
| Financing cash flow | $21.00M | -$293.00M | -$165.00M | $1.36B | -$286.00M | -$1.28B | $914.00M | -$57.00M | -$153.00M | -$900.00M |
| Net change in cash | -$2.23B | $486.00M | $264.00M | $1.29B | -$416.00M | -$679.00M | $1.55B | -$547.00M | $59.00M | $86.00M |
| Stock-based compensation | $35.00M | $36.00M | $38.00M | $34.00M | $22.00M | $33.00M | $22.00M | $36.00M | $34.00M | $33.00M |
| Common dividends paid | $16.00M | $16.00M | $16.00M | $16.00M | $16.00M | $14.00M | $13.00M | $14.00M | $14.00M | $13.00M |
| Common share repurchases | $100.00M | $0 | $100.00M | $100.00M | $0 | $0 | $0 | Unavailable | Unavailable | Unavailable |
| Depreciation & amortization | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Derived
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Gross margin | 38.5% | 39.7% | 38.7% | 39.6% | 42.1% | 42.8% | 41.7% | 41.4% | 40.9% | 41.4% |
| Operating margin | 10.0% | 14.5% | 12.7% | 13.1% | 13.2% | 15.1% | 13.9% | 12.6% | 11.6% | 13.2% |
| FCF margin | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| SBC / revenue | 0.7% | 0.6% | 0.7% | 0.7% | 0.5% | 0.6% | 0.5% | 0.7% | 0.7% | 0.6% |
| Current ratio | 1.22x | 1.37x | 1.18x | 1.16x | 0.98x | 1.04x | 1.23x | 1.06x | 1.06x | 1.05x |
| Revenue YoY growth | 7.4% | 7.1% | 5.8% | 3.5% | 2.7% | 2.2% | 0.9% | 0.5% | -1.2% | 5.4% |
| Net margin | 7.6% | 10.3% | 8.7% | 9.7% | 11.8% | 13.6% | 9.7% | 8.8% | 8.0% | 7.7% |
| R&D / revenue | 6.7% | 5.7% | 5.7% | 6.0% | 7.2% | 6.5% | 6.5% | 6.8% | 7.0% | 6.1% |
| CapEx / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Long-term debt / equity | 0.95x | 0.91x | 0.83x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 18.6% | 26.7% | 27.8% | 18.4% | 15.0% | 11.5% | 25.5% | 24.7% | 24.2% | 31.7% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open GEHC in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-04-29View SEC filing
10-K · Filed 2026-02-04View SEC filing
10-Q · Filed 2025-10-29View SEC filing
10-Q · Filed 2025-07-30View SEC filing
10-Q · Filed 2025-04-30View SEC filing
10-K · Filed 2025-02-13View SEC filing
Companies in the same industry
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.